Weight Loss

The weight-loss drug Wegovy is shown in this undated handout photo. The makers of Ozempic say the weight-loss drug Wegovy will be available to patients in Canada starting Monday, May 6. THE CANADIAN PRESS/HO, Novo Nordisk Canada Inc. *MANDATORY CREDIT*

Weight loss drug Wegovy arriving in Canada next week

Drug to be used to treat obesity and related medical conditions, not intended for ‘cosmetic’ use

 

FILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis on April 26, 2017. A new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight. (AP Photo/Darron Cummings, File)

Drug used in diabetes treatment Mounjaro helped dieters shed 60 pounds: study

Drug had to be combined with intensive diet and exercise

 

A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, manufacturer Novo Nordisk says. The injectable drug Ozempic is shown in Houston, Saturday, July 1, 2023. THE CANADIAN PRESS/AP-David J. Phillip

Shortage of diabetes and weight loss drug Ozempic pending in Canada

Manufacturer says global supply structure creating issues that will be felt into the fall

 

An advertisement for Ozempic is seen on a billboard in Toronto on Friday, June 16, 2023. THE CANADIAN PRESS/Cole Burston

Ozempic ads seem to be everywhere, doctors and ethics experts are worried

Increased attention on diabetes drug turned weight loss treatment has watchdogs on alert

An advertisement for Ozempic is seen on a billboard in Toronto on Friday, June 16, 2023. THE CANADIAN PRESS/Cole Burston
This image provided by Eli Lilly shows a 15 mg dosage of the company’s drug Mounjaro. Already approved to treat type 2 diabetes, Mounjaro is being considered for fast-track approval as a weight-loss drug based on the results of key clinical trials, with the latest announced on Thursday, April 27, 2023. Also known as tirzepatide, it is part of new class of medications that treat overweight and obesity by targeting the metabolic conditions that lead to extra weight. (Eli Lilly via AP)

Powerful new obesity drug poised to upend weight loss care

Tirzepatide, marketed as Mounjaro, has a track record of leading to significant weight loss

This image provided by Eli Lilly shows a 15 mg dosage of the company’s drug Mounjaro. Already approved to treat type 2 diabetes, Mounjaro is being considered for fast-track approval as a weight-loss drug based on the results of key clinical trials, with the latest announced on Thursday, April 27, 2023. Also known as tirzepatide, it is part of new class of medications that treat overweight and obesity by targeting the metabolic conditions that lead to extra weight. (Eli Lilly via AP)
The Canadian Pharmacists Association says protecting Canadian drug supplies from mass exportation to the U.S. market remains a priority in light of B.C.’s recent move to limit sales of the diabetes drug Ozempic, which has been hyped as a weight-loss treatment. Prescription drugs are seen on shelves at a pharmacy in Montreal on March 11, 2021. THE CANADIAN PRESS/Ryan Remiorz

Rush for diabetes and weight-loss drug Ozempic puts cross-border sales in spotlight

Large-scale American demand for cheaper Canadian drugs threaten country’s supplies

The Canadian Pharmacists Association says protecting Canadian drug supplies from mass exportation to the U.S. market remains a priority in light of B.C.’s recent move to limit sales of the diabetes drug Ozempic, which has been hyped as a weight-loss treatment. Prescription drugs are seen on shelves at a pharmacy in Montreal on March 11, 2021. THE CANADIAN PRESS/Ryan Remiorz
B.C. Health Minister Adrian Dix pauses while responding to questions during a news conference in Vancouver on Monday, November 7, 2022. Dix plans to announce actions on how the government will ensure patients in the province will have secure access to the diabetes and weight loss drug Ozempic. THE CANADIAN PRESS/Darryl Dyck

B.C. to announce plan for access to diabetes drug Ozempic, hyped for weight loss

Almost 10 per cent of prescriptions for the drug in B.C. filled for Americans

B.C. Health Minister Adrian Dix pauses while responding to questions during a news conference in Vancouver on Monday, November 7, 2022. Dix plans to announce actions on how the government will ensure patients in the province will have secure access to the diabetes and weight loss drug Ozempic. THE CANADIAN PRESS/Darryl Dyck
Kerry Toneguzzi poses for a portrait at her home in Kanata, Ont., on Tuesday, March 7, 2023. When she was diagnosed with diabetes in the fall of 2020, her doctor suggested she try Ozempic – a drug approved in Canada to treat diabetes, with a frequent side effect of weight loss. THE CANADIAN PRESS/Spencer Colby

Despite social media buzz, Ozempic is not a quick-fix weight loss solution: doctors

Diabetes treatment gaining popularity but doctors say it’s not a simple path to a bikini body

Kerry Toneguzzi poses for a portrait at her home in Kanata, Ont., on Tuesday, March 7, 2023. When she was diagnosed with diabetes in the fall of 2020, her doctor suggested she try Ozempic – a drug approved in Canada to treat diabetes, with a frequent side effect of weight loss. THE CANADIAN PRESS/Spencer Colby
IMAGE DISTRIBUTED FOR WEIGHT WATCHERS - At a WW GOOD wellness festival powered by Weight Watchers "WW" on the Santa Monica Pier on August 11, 2018, Los Angeles residents engage in a movement and meditation series ("LIFTED") led by Celebrity Fitness Instructor Holly Rilinger. WW International, better known as WeightWatchers, is buying telehealth platform Sequence, giving its members access to a program that offers prescriptions to obesity medications. Shares of WW International Inc. jumped nearly 12% before the market open on Tuesday, March 7, 2023. (Matt Sayles/AP Images for Weight Watchers)

WeightWatchers gets into prescription weight loss business

WeightWatchers soared Tuesday after the company said it was getting into the…

IMAGE DISTRIBUTED FOR WEIGHT WATCHERS - At a WW GOOD wellness festival powered by Weight Watchers "WW" on the Santa Monica Pier on August 11, 2018, Los Angeles residents engage in a movement and meditation series ("LIFTED") led by Celebrity Fitness Instructor Holly Rilinger. WW International, better known as WeightWatchers, is buying telehealth platform Sequence, giving its members access to a program that offers prescriptions to obesity medications. Shares of WW International Inc. jumped nearly 12% before the market open on Tuesday, March 7, 2023. (Matt Sayles/AP Images for Weight Watchers)